Those holding MTL Cannabis Corp. (CSE:MTLC) shares would be relieved that the share price has rebounded 27% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. Looking back a bit further, it’s encouraging to see the stock is up 95% in the last year.
Even after such a large jump in price, you could still be forgiven for feeling indifferent about MTL Cannabis’ P/S ratio of 0.7x, since the median price-to-sales (or “P/S”) ratio for the Pharmaceuticals industry in Canada is about the same. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.
We’ve discovered 4 warning signs about MTL Cannabis. View them for free.
Check out our latest analysis for MTL Cannabis
